Stock RNXT RENOVORX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar RenovoRx, Inc.

Equities

RNXT

US75989R1077

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.243 USD +2.73% Intraday chart for RenovoRx, Inc. +6.24% -45.72%
Apr. 16 RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting CI
Apr. 15 RenovoRx, Inc. announced that it has received $11.136652 million in funding CI

Chart calendar RenovoRx, Inc.

2ba65fa8b19714572eff87a2aad7a.XGdFQ-mWo1qtBcrfo8j2SYvLnXWFUbukj7R87hZoaLk.BSVwdtrT5mzuNKeez6WBO_yb2kbQAvDT2PlPu15fRYBuCXR6meTwCN1mmw~c1bc9f04cd170be85112cdceaa915b81

Upcoming events on RenovoRx, Inc.

2024-05-12 Q1 2024 Earnings Release (Projected)
2024-08-13 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)

Past events on RenovoRx, Inc.

2024-04-15 08:00 am CG Horizons in Oncology Virtual Conference
2024-03-22 Society Of Interventional Radiology Scientific Meeting - Abstract No:1632169
2024-03-19 01:00 pm Roth Conference
2023-12-15 01:00 pm Extraordinary Shareholders Meeting
2023-11-14 08:30 am Q3 2023 Earnings Release
2023-10-12 11:30 am Roth Healtcare Opportunities Conference
2023-08-17 08:30 am Q2 2023 Earnings Release
2023-08-10 10:30 am Canaccord Genuity Growth Conference
2023-06-29 02:50 am ESMO Gastrointestinal Cancer World Congress - Abstract Number : LBA-1
2023-06-15 10:00 am Investor Meeting - Key Opinion Leader
2023-06-08 12:00 pm Annual General Meeting
2023-06-06 04:00 pm LD Micro Invitational Conference
2023-05-15 08:30 am Q1 2023 Earnings Release
2023-05-03 03:30 pm Aegis Capital Virtual Conference
2023-04-17 09:00 am American Association for Cancer Research Meeting
2023-03-13 05:00 pm Roth Conference
2023-03-02 07:30 am Q4 2022 Earnings Release
2023-02-02 04:00 pm Sequire Biotechnology Conference
2023-01-18 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
2022-11-14 08:30 am Q3 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-5,67
-4,53
-25.1%		-9,95
-10,2
2.33%		-11,4
-12,9
11.87%
-8,55

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-6,32
-5,36
-17.92%		-9,89
-10,1
2.11%		-10,2
-10,3
0.82%
-8,12

Net income
Million USD		Released
Forecast
Spread 		-3,80


-6,32
-5,36
-17.92%		-9,89
-10,1
2.11%		-10,2
-10,3
0.82%
-8,12

EPS
USD		Released
Forecast
Spread 		-0,34


-1,21
-1,24
2.42%		-1,09
-1,12
2.24%		-0,99
-1,01
1.49%
-0,32

Announcement Date02/04/2130/03/2202/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-2,36
-1,22
-93.27%		-3,01
-2,02
-48.73%		-2,61
-2,63
0.42%		-2,16
-2,67
19.2%		-2,17
-2,41
9.85%		-3,26
-2,38
-36.82%		-3,38
-2,97
-13.5%		-2,98
-3,34
10.77%		-1,78
-3,31
46.35%
-2,25


-2,10


-2,10


-2,10




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-2,36
-1,39
-68.94%		-3,00
-1,98
-51.44%		-2,59
-2,60
0.04%		-2,14
-2,64
19.23%		-2,16
-2,37
9.01%		-3,26
-2,37
-37.37%		-2,33
-2,96
21.41%		-1,42
-3,33
57.33%		-3,23
-3,31
2.57%
-2,19


-1,96


-1,98


-1,99




Net income
Million USD		Released
Forecast
Spread 		-2,36
-1,39
-68.94%		-3,00
-1,98
-51.44%		-2,59
-2,60
0.04%		-2,14
-2,64
19.23%		-2,16
-2,37
9.01%		-3,26
-2,37
-37.37%		-2,33
-2,96
21.41%		-1,42
-3,33
57.33%		-3,23
-3,31
2.57%
-2,19


-1,96


-1,98


-1,99




EPS
USD		Released
Forecast
Spread 		-0,12
-0,19
36.84%		-0,33
-0,21
-57.14%		-0,29
-0,29
-1.75%		-0,24
-0,29
17.24%		-0,23
-0,26
11.54%		-0,36
-0,22
-67.44%		-0,22
-0,29
24.14%		-0,13
-0,28
53.57%		-0,30
-0,31
1.64%
-0,13


-0,08


-0,07


-0,07




Announcement Date30/03/2213/05/2212/08/2214/11/2202/03/2312/05/2316/08/2313/11/2301/04/24-----

Upcoming sector events for RenovoRx, Inc.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for RenovoRx, Inc.

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 04:05 pm PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RNXT Stock
  4. Calendar RenovoRx, Inc.